Atara Biotherapeutics ATRA
NASDAQ ATRA
$8.46 -0.04 (-0.47%)
At close: Oct 1, 2026 · 4:00 PM EDT

Atara Biotherapeutics (ATRA) Return on Assets [ROA] (2014 - 2026)

Updated

Atara Biotherapeutics (ATRA) posted Return on Assets [ROA] of -81.36% for Q2 2026, down 93.08 percentage points from 11.71% a year earlier and down 34.30 percentage points from the prior quarter.

Analysis

Atara Biotherapeutics (ATRA) Return on Assets [ROA] (2014 - 2026) Analysis & Trends

For FY2025, Atara Biotherapeutics' Return on Assets [ROA] came in at 50.55%, up 112.75 percentage points from FY2024.

  • Annual Return on Assets [ROA] shows a five-year change of +116.41 percentage points (FY2020 to FY2025).
  • In prior years, Atara Biotherapeutics' Return on Assets [ROA] was -62.20% in FY2024 (+39.70 pp), -101.91% in FY2023 (-47.84 pp), -54.06% in FY2022 (+10.34 pp) and -64.41% in FY2021 (+1.46 pp).
  • The Q2 2026 figure stands as the lowest quarterly Return on Assets [ROA] since Q3 2024.
  • On a year-over-year basis, Return on Assets [ROA] increased in six of the last eight quarters, with an average year-over-year change of +78.68 percentage points.
  • The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q4 2025, with a gain of 197.54 percentage points; the weakest was Q4 2023, with a drop of 94.56 percentage points.
  • According to Business Quant data, Return on Assets [ROA] for the three prior quarters was -47.06% (Q1 2026), 129.71% (Q4 2025) and 69.78% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.47%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 4.65%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.45%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 28.37%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.10%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 9.29%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -6.13%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.14%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 16.34%
10 Atara Biotherapeutics 127.78 Mn 117.88 Mn 439,000.00 -81.36%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -81.36%
Mar 31, 2026 -47.06%
Dec 31, 2025 129.71%
Sep 30, 2025 69.78%
Jun 30, 2025 11.71%
Mar 31, 2025 -18.28%
Dec 31, 2024 -67.83%
Sep 30, 2024 -102.43%
Jun 30, 2024 -128.15%
Mar 31, 2024 -140.95%
Dec 31, 2023 -155.87%
Sep 30, 2023 -133.38%
Jun 30, 2023 -111.04%
Mar 31, 2023 -63.37%
Dec 31, 2022 -61.31%
Sep 30, 2022 -61.43%
Jun 30, 2022 -59.43%
Mar 31, 2022 -80.87%
Dec 31, 2021 -74.10%
Sep 30, 2021 -72.37%
API Access

Atara Biotherapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ATRA&period=max&api_key=YOUR_API_KEY